en

PRODUCT DETAIL

Sitagliptin HCS 25 mg filmom obalené tablety

Code 3431E
MA number 18/0093/23-S
Product Form: tbl flm 14x25 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: HCS BV, Belgium
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH01 Sitagliptin
Shelf life: 24
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 15.05.2023
Validity: 15.05.2028
PIL: PIL_Sitagliptin HCS 25 mg, 50 mg, 100 mg tbl flm_08.2024.pdf  
SPC: SPC_Sitagliptin HCS 25 mg, 50 mg, 100 mg tbl flm_08.2024.pdf  
Safety feature Yes
Data update: 16.05.2023
eu-flag.png sk-flag.png